Sabra Healthcare Reit Stock Performance
| SBRA Stock | USD 17.34 0.00 0.00% |
Sabra Healthcare has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 0.43, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sabra Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sabra Healthcare is expected to be smaller as well. Sabra Healthcare REIT right now has a risk of 1.66%. Please validate Sabra Healthcare coefficient of variation, maximum drawdown, skewness, as well as the relationship between the total risk alpha and downside variance , to decide if Sabra Healthcare will be following its existing price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Sabra Healthcare REIT are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Sabra Healthcare is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.40) | Five Day Return (2.49) | Year To Date Return 1.23 | Ten Year Return (48.69) | All Time Return (58.22) |
Forward Dividend Yield 0.0695 | Payout Ratio | Last Split Factor 1:3 | Forward Dividend Rate 1.2 | Dividend Date 2025-02-28 |
1 | Acquisition by Richard Matros of 14317 shares of Sabra Healthcare subject to Rule 16b-3 | 01/06/2025 |
2 | Sabra Health Care just upgraded at JMP Securities, heres why SBRA | 01/07/2025 |
3 | Acquisition by Richard Matros of 285144 shares of Sabra Healthcare subject to Rule 16b-3 | 01/15/2025 |
4 | Acquisition by Malehorn Jeffrey A. of 826 shares of Sabra Healthcare subject to Rule 16b-3 | 01/31/2025 |
5 | Sabra Health Care REIT Inc Announces Q4 2024 Earnings Release Date and Dividend Declaration | 02/03/2025 |
6 | Acquisition by Porter Clifton J Ii of 798 shares of Sabra Healthcare subject to Rule 16b-3 | 02/06/2025 |
7 | Sabra Health Care REIT Inc Announces Participation in Key 2025 Conferences | 02/19/2025 |
8 | Sabra Health Care REIT, Inc. Q4 2024 Earnings Call Transcript | 02/21/2025 |
9 | Acquisition by Cusack Catherine of 1500 shares of Sabra Healthcare at 15.92 subject to Rule 16b-3 | 02/24/2025 |
10 | Directors Bold Move Major Investment in Sabra Healthcare REIT - TipRanks | 02/25/2025 |
11 | Acquisition by Richard Matros of 14676 shares of Sabra Healthcare subject to Rule 16b-3 | 02/28/2025 |
12 | Extra Space Storages Store Count Surpasses 4,000 Nationwide | 03/06/2025 |
13 | American Tower Hikes Dividend by 4.9 percent Is it Sustainable | 03/07/2025 |
14 | Welltower Stock Gains 14.5 percent in 3 Months Will it Continue to Rise | 03/12/2025 |
15 | Sabra Health Care REIT Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat | 03/19/2025 |
| Begin Period Cash Flow | 46.7 M |
Sabra |
Sabra Healthcare Relative Risk vs. Return Landscape
If you would invest 1,677 in Sabra Healthcare REIT on December 24, 2024 and sell it today you would earn a total of 43.00 from holding Sabra Healthcare REIT or generate 2.56% return on investment over 90 days. Sabra Healthcare REIT is currently generating 0.0552% in daily expected returns and assumes 1.6639% risk (volatility on return distribution) over the 90 days horizon. In different words, 14% of stocks are less volatile than Sabra, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sabra Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sabra Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sabra Healthcare REIT, and traders can use it to determine the average amount a Sabra Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0332
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | SBRA | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.66 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Sabra Healthcare is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sabra Healthcare by adding it to a well-diversified portfolio.
Sabra Healthcare Fundamentals Growth
Sabra Stock prices reflect investors' perceptions of the future prospects and financial health of Sabra Healthcare, and Sabra Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sabra Stock performance.
| Return On Equity | 0.0457 | ||||
| Return On Asset | 0.03 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.37 % | ||||
| Current Valuation | 6.49 B | ||||
| Shares Outstanding | 237.91 M | ||||
| Price To Earning | 67.37 X | ||||
| Price To Book | 1.50 X | ||||
| Price To Sales | 5.84 X | ||||
| Revenue | 703.24 M | ||||
| Gross Profit | 476.12 M | ||||
| EBITDA | 412.61 M | ||||
| Net Income | 126.71 M | ||||
| Cash And Equivalents | 49.05 M | ||||
| Cash Per Share | 0.21 X | ||||
| Total Debt | 1.76 B | ||||
| Debt To Equity | 0.76 % | ||||
| Current Ratio | 0.78 X | ||||
| Book Value Per Share | 11.54 X | ||||
| Cash Flow From Operations | 310.54 M | ||||
| Earnings Per Share | 0.54 X | ||||
| Market Capitalization | 4.11 B | ||||
| Total Asset | 5.3 B | ||||
| Retained Earnings | (1.87 B) | ||||
| Working Capital | 355.11 M | ||||
| Current Asset | 17.25 M | ||||
| Current Liabilities | 35.18 M | ||||
About Sabra Healthcare Performance
By analyzing Sabra Healthcare's fundamental ratios, stakeholders can gain valuable insights into Sabra Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sabra Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sabra Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 831.07 | 872.63 | |
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | 0.04 | 0.05 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.05 | 0.04 |
Things to note about Sabra Healthcare REIT performance evaluation
Checking the ongoing alerts about Sabra Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sabra Healthcare REIT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sabra Healthcare REIT currently holds 1.76 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity. | |
| Over 99.0% of Sabra Healthcare shares are owned by institutional investors | |
| Latest headline from news.google.com: Sabra Health Care REIT Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat |
- Analyzing Sabra Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sabra Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Sabra Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sabra Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sabra Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sabra Healthcare's stock. These opinions can provide insight into Sabra Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sabra Stock analysis
When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |